Skip to main content

Advertisement

Log in

Maternal Basic Fibroblast Growth Factor Serum Levels Are Associated With Pregnancy-Induced Hypertension

  • Original Article
  • Published:
The Journal of the Society for Gynecologic Investigation: JSGI Aims and scope Submit manuscript

Abstract

Objective

TO test the hypothesis that serum levels of basic fibroblast growth f actor (bFGF) are altered among women with pregnancy-induced hypertension (PIH) and are associated with disease severity.

Methods

We evaluated serum levels of bFGF in 46 women with PIH, 46 age- and parity-matched healthy pregnant women, and 46 healthy nonpregnant controls. Enzyme-linked immunosorbent assays were used to determine serum levels of bFGF. Results were correlated to clinical data.

Results

The overall mean serum levels of bFGF were 3.2 (standard deviation [SD] 9.3) μmol/L. Mean serum levels of bFGF in normal controls, healthy pregnant women, and women with PIH were 0 (SD 0) μmol/L, 2.6 (SD 6.3) μmol/L, and 6.8 (SD 13.8) μmol/L, respectively (P = .003) for normal controls compared with healthy pregnant women and P < .001 for healthy pregnant women compared with women with PIH). In a univariate logistic regression model bFGF showed a significant influence on the odds of presenting with PIH compared with healthy pregnant women (P = .002). The mean serum levels of bFGF in women with severe PIH and in women with mild PIH were 4.4 (SD 10.6) μmol/L and 9.5 (SD 17.3) μmol/L, respectively (P = .1). In a univariate logistic regression model bFGF did not reveal a significant influence on the odds of developing severe PIH (P = .3).

Conclusions

Elevated serum levels of bFGF are associated with PIH, but bFGF does not seem to be a useful prognostic parameter for severe PIH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Baird A, Klagsbrun M. The fibroblast growth factor family. Cancer Cells 1991;3:239–43.

    CAS  PubMed  Google Scholar 

  2. Dono R, Texido G, Dussel R, Ehmke H, Zeiler R. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J 1998;17:4213–25.

    Article  CAS  Google Scholar 

  3. Krishnamurthy P, Bird IM, Sheppard C, Magness RR. Effects of angiogenic growth factors on endothelium-derived prostacyclin production by ovine uterine and placental arteries. Prostaglandins Other Lipid Mediat 1999;57:1–12.

    Article  CAS  Google Scholar 

  4. Peifley KA, Winkles JA. Angiotensin II and endothelin-1 increase fibroblast growth factor-2 mRNA expression in vascular smooth muscle cells. Biochem Biophys Res Commun 1998;242: 202–8.

    Article  CAS  Google Scholar 

  5. Cottone S, Vella MC, Vadala A, Neri AL, Riccobene R, Cerasola G. Influence of vascular load on plasma endothelin-1, cytokines and catecholamine levels in essential hypertensives. Blood Press 1998;7:144–8.

    Article  CAS  Google Scholar 

  6. Bird IM, Sullivan JA, Di T, Cale JM, Zhang L, Zheng J, et al. Pregnancy-dependent changes in cell signaling underlie changes in differential control of vasodilator production in uterine artery endothelial cells. Endocrinology 2000;141:1107–17.

    Article  CAS  Google Scholar 

  7. Damon DH, Lange DL, Hattier BG. In vitro and in vivo vascular actions of basic fibroblast growth factor (bFGF) in normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol 1997;30:278–84.

    Article  CAS  Google Scholar 

  8. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. ACOG technical bulletin no. 219. Washington, DC: American College of Obstetricians and Gynecologists, 1996.

    Google Scholar 

  9. Srivastava RK, Gu Y, Ayloo S, Zilberstein M, Gibori G. Developmental expression and regulation of basic fibroblast growth foctor and vascular endothelial growth factor in rat decidua and in a decidual cell line. J Mol Endocrinol 1998;21:355–62.

    Article  CAS  Google Scholar 

  10. Hill DJ, Flyvbjerg A, Arany E, Lauszus FF, Klebe JG. Increased levels of serum fibroblast growth factor-2 in diabetic pregnant women with retinopathy. J Clin Endocrinol Metab 1997;82: 1452–7.

    CAS  PubMed  Google Scholar 

  11. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200–4.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clemens Tempfer MD.

Additional information

The authors thank Ingrid Schiebel for expert technical assistance.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurz, C., Hefler, L., Zeisler, H. et al. Maternal Basic Fibroblast Growth Factor Serum Levels Are Associated With Pregnancy-Induced Hypertension. Reprod. Sci. 8, 24–26 (2001). https://doi.org/10.1177/107155760100800104

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/107155760100800104

Key words

Navigation